BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8982041)

  • 1. An improved animal model for studying desferrioxamine.
    Steward A; Williamson I; Madigan T; Bretnall A; Hassan IF
    Br J Haematol; 1996 Dec; 95(4):654-9. PubMed ID: 8982041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposome-encapsulated desferrioxamine in experimental iron overload.
    Lau EH; Cerny EA; Rahman YE
    Br J Haematol; 1981 Apr; 47(4):505-18. PubMed ID: 7213574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of iron chelation by desferrioxamine entrapped in red blood cell ghosts.
    Green R; Miller J; Crosby W
    Blood; 1981 May; 57(5):866-72. PubMed ID: 7214016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobilisation of iron from peritoneal rat macrophages by desferrioxamine.
    Kleber EE; Torrance JD; Bothwell TH; Simon MO; Charlton RW
    Scand J Haematol; 1981 Sep; 27(3):209-18. PubMed ID: 7313547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chelation of transferrin iron by desferrioxamine in K562 cells. The partition of iron between ferrioxamine and ferritin.
    Roberts S; Bomford A
    Biochem J; 1988 Sep; 254(3):869-75. PubMed ID: 3196300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.
    Kontoghiorghes GJ; Sheppard L; Hoffbrand AV; Charalambous J; Tikerpae J; Pippard MJ
    J Clin Pathol; 1987 Apr; 40(4):404-8. PubMed ID: 3584483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte iron kinetics in the rat explored with an iron chelator.
    Pippard MJ; Johnson DK; Finch CA
    Br J Haematol; 1982 Oct; 52(2):211-24. PubMed ID: 7126464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo iron mobilisation evaluation of hydroxypyridinones in 59Fe-ferritin-loaded rat model.
    Liu ZD; Lu SL; Hider RC
    Biochem Pharmacol; 1999 Mar; 57(5):559-66. PubMed ID: 9952320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desferrioxamine induced urinary iron excretion in thalassemia.
    Dubey AP; Kumar S; Choudhury P; Talukdar B; Puri RK
    Indian Pediatr; 1993 Jun; 30(6):775-8. PubMed ID: 8132258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron mobilization from cultured hepatocytes: effect of desferrioxamine B.
    Octave JN; Schneider YJ; Crichton RR; Trouet A
    Biochem Pharmacol; 1983 Nov; 32(22):3413-8. PubMed ID: 6651865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies in desferrioxamine and ferrioxamine metabolism in normal and iron-loaded subjects.
    Summers MR; Jacobs A; Tudway D; Perera P; Ricketts C
    Br J Haematol; 1979 Aug; 42(4):547-55. PubMed ID: 476006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced iron removal from liver parenchymal cells in experimental iron overload: liposome encapsulation of HBED and phenobarbital administration.
    Rahman YE; Cerny EA; Lau EH; Carnes BA
    Blood; 1983 Jul; 62(1):209-13. PubMed ID: 6407548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an intravenous desferrioxamine mesylate treatment protocol for swine: monitoring of desferrioxamine and metabolites by high-performance liquid chromatography.
    Fisher EA; McLachlan DR; Kruck TP; Mustard RA
    Pharmacology; 1990; 41(5):263-71. PubMed ID: 2092330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of interferon and desferrioxamine on serum ferritin and hepatic iron concentrations in chronic hepatitis B.
    Bayraktar Y; Saglam F; Temizer A; Uzunalimodlu B; van Thiel DH
    Hepatogastroenterology; 1998; 45(24):2322-7. PubMed ID: 9951916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fate of intravenously injected tissue ferritin in pregnant guinea-pigs.
    Lamparelli RD; Friedman BM; MacPhail AP; Bothwell TH; Phillips JI; Baynes RD
    Br J Haematol; 1989 May; 72(1):100-5. PubMed ID: 2736234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Storage iron kinetics. 3. Study of desferrioxamine action by selective radioiron labels of RE and parenchymal cells.
    Hershko C; Cook JD; Finch DA
    J Lab Clin Med; 1973 Jun; 81(6):876-86. PubMed ID: 4196982
    [No Abstract]   [Full Text] [Related]  

  • 17. Liposome entrapped desferrioxamine and iron transporting ionophores: a new approach to iron chelation therapy.
    Young SP; Baker E; Huehns ER
    Br J Haematol; 1979 Mar; 41(3):357-63. PubMed ID: 427040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic analysis of desferrioxamine. Pharmacokinetic and metabolic studies.
    Kruck TP; Teichert-Kuliszewska K; Fisher E; Kalow W; McLachlan DR
    J Chromatogr; 1988 Dec; 433():207-16. PubMed ID: 3235548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of desferrioxamine, rhodotorulic acid and cholylhydroxamic acid on transferrin and iron exchange with hepatocytes in culture.
    Baker E; Page M; Torrance J; Grady R
    Clin Physiol Biochem; 1985; 3(6):277-88. PubMed ID: 4075694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of iron from an oral dose into the ferritin of the duodenal mucosa and the liver of normal and iron-deficient rats.
    Ehtechami C; Elsenhans B; Forth W
    J Nutr; 1989 Feb; 119(2):202-10. PubMed ID: 2918392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.